EP Patent

EP3088400A1 — Pyrrolo[2,3-b]pyridine derivatives as protein kinase inhibitors

Assigned to Plexxikon Inc · Expires 2016-11-02 · 10y expired

What this patent protects

Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

USPTO Abstract

Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

Drugs covered by this patent

Patent Metadata

Patent number
EP3088400A1
Jurisdiction
EP
Classification
—
Expires
2016-11-02
Drug substance claim
No
Drug product claim
No
Assignee
Plexxikon Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.